It's been a confusing week for women.
The new mammogram recommendations out earlier this week caused quite an uproar. Now comes another change in screening tests for women -- this one for cervical cancer.
Young women should have their first Pap test no sooner than age 21, regardless of when they become sexually active, say new guidelines from the American College of Obstetricians and Gynecologists. Earlier screening for cervical cancer may lead to unnecessary and possibly harmful treatments for an increasingly rare cancer, according to ACOG, the leading U.S. professional organization for obstetricians and gynecologists.
The Food and Drug Administration approved a second vaccine intended to protect against cervical cancer.
The death of a 14-year-old girl in England after she received a vaccination for Human Papilloma virus (HPV) has prompted a widespread freeze on the country's national vaccination program.
Men with prostate cancer who were previously infected with the sexually transmitted germ Trichomonas vaginalis are more likely to have an aggressive form of the cancer, compared with men who never had the STD, a new study says.
Boys may soon be able to get Gardasil, the vaccine given to girls and young women to prevent infection by four types of human papillomavirus.
One in four American girls ages 13 to 17 have been given at least one shot of Gardasil, the human papillomavirus vaccine that is heavily marketed as a way to prevent cervical cancer.
When Raffi Darrow brought in her two daughters, Wendy and Alice, for their annual back-to-school checkups this week, for the first time in her career as a mom, Darrow decided to be a rebel.
What exactly does a routine Pap smear screen do? Does it screen for human papillomavirus, cancers or both? Since I have no risk of sexually transmitted diseases because my spouse and I have had sexual contact only with one another, is a Pap smear a pointless procedure, for me in particular? Can a Pap smear detect cancers other than those caused by HPV or other STDs? What other reasons, if any, are there for me to get a Pap smear, and what other tests or procedures should a healthy, monogamous 27-year-old have at the OB/GYN? And how often should she have them?
It's been a confusing week for women.
The new mammogram recommendations out earlier this week caused quite an uproar. Now comes another change in screening tests for women -- this one for cervical cancer.
Young women should have their first Pap test no sooner than age 21, regardless of when they become sexually active, say new guidelines from the American College of Obstetricians and Gynecologists. Earlier screening for cervical cancer may lead to unnecessary and possibly harmful treatments for an increasingly rare cancer, according to ACOG, the leading U.S. professional organization for obstetricians and gynecologists.
The Food and Drug Administration approved a second vaccine intended to protect against cervical cancer.
The death of a 14-year-old girl in England after she received a vaccination for Human Papilloma virus (HPV) has prompted a widespread freeze on the country's national vaccination program.
Men with prostate cancer who were previously infected with the sexually transmitted germ Trichomonas vaginalis are more likely to have an aggressive form of the cancer, compared with men who never had the STD, a new study says.
Boys may soon be able to get Gardasil, the vaccine given to girls and young women to prevent infection by four types of human papillomavirus.
One in four American girls ages 13 to 17 have been given at least one shot of Gardasil, the human papillomavirus vaccine that is heavily marketed as a way to prevent cervical cancer.
When Raffi Darrow brought in her two daughters, Wendy and Alice, for their annual back-to-school checkups this week, for the first time in her career as a mom, Darrow decided to be a rebel.
What exactly does a routine Pap smear screen do? Does it screen for human papillomavirus, cancers or both? Since I have no risk of sexually transmitted diseases because my spouse and I have had sexual contact only with one another, is a Pap smear a pointless procedure, for me in particular? Can a Pap smear detect cancers other than those caused by HPV or other STDs? What other reasons, if any, are there for me to get a Pap smear, and what other tests or procedures should a healthy, monogamous 27-year-old have at the OB/GYN? And how often should she have them?
Is Gardasil vaccination reliable? I've heard plenty of ugly things about this vaccination. I have a 17-year-old daughter and her doctor recommends that she get this vaccine. I am very confused because of the negative and positive information. Would you be able to clarify?
Men who are circumcised are less likely to get sexually transmitted infections such as genital herpes and human papillomavirus (HPV), but not syphilis, according to a study of adult African men published this week in the New England Journal of Medicine.
Cancer screenings are up, as are hits on the disease's U.K. Web site
A new British study has discovered that the highest rates of cervical cancer are found in some of London's most deprived areas.
A staggering 99 percent of all cervical cancers are caused by the human papillomavirus (HPV), according to the American Cancer Society. For 50 years, the Pap test has been the gold standard for detecting cervical cancer. But there's a new kid on the block: the HPV DNA test.
Genital human papillomavirus, or HPV, which infects the skin and mucous membranes, is the most common sexually transmitted disease. About 20 million Americans have the virus, according to the Centers for Disease Control and Prevention. HPV is the major cause of cervical cancer, which kills about 250,000 women worldwide each year. In the United States, cervical cancer will be diagnosed in about 12,000 women this year, and 4,000 will die, the CDC says. Women get Pap smears to detect cervical cancer and now have the option of preventing it with a vaccine. Gardasil, developed by Merck, works to protect against four strains of HPV, including two connected to 70 percent of cervical cancers.
About one in four teen girls last year got the groundbreaking vaccine that prevents cervical cancer, federal health officials reported Thursday.
About one in four teen girls last year got the groundbreaking vaccine that prevents cervical cancer, federal health officials reported Thursday
The cervical cancer vaccine Gardasil also works to prevent cancers of the vagina and vulva, federal health officials said Friday, as they approved expanding its use to protect against those diseases as well
An expensive vaccine aimed at preventing cervical cancer makes sense for young teens when it comes to cost-effectiveness, but not for women in their 20s, contends a new report
A vaccine designed to prevent cervical cancer is coming under fresh scrutiny amid thousands of complaints linking it to a range of health problems.
Merck's drug against HPV has been a boon to the company but is facing growing grass-roots opposition
Teenagers may be more susceptible than adults to certain types of cancer, including cervical, testicular and skin cancer
I'm the mother of two daughters, a teen and a tween. So every day, I tiptoe through hormonally laced minefields hoping to avoid emotional carnage in response to any of my random comments or actions.
Merck & Co. reported a surge in fourth-quarter operating earnings Wednesday that exceeded analysts' estimates, but shares slumped in early trading.
The drugmaker Merck & Co. said Tuesday that it will seek federal approval for two new experimental drugs next year, adding that it's on track to meet its sales targets.
Merck failed to excite investors with its financial guidance for 2007 and 2008, causing a temporary stock drop, but analysts were reluctant to condemn the drugmaker.
Merck's cervical cancer vaccine Gardasil now faces direct competition from Glaxo's Cervarix, which was approved by European health authorities, said the vaccine's maker GlaxoSmithKline on Monday.
The FDA has approved the vaccine only for girls and women up to age 26. Now a medical debate is raging over whether older women should get it too
Men should be vaccinated against a sexually transmitted wart virus to protect them against a type of mouth and throat cancer, U.S. researchers said Monday.
TThe drug helps protect teenage girls from the virus that can cause cervical cancer, but a new study shows it does little to help women who already are already infected
Merck & Co. said Monday that quarterly earnings rose 12 percent on strong demand for its newer vaccines and medicines, and raised its 2007 profit forecast, sending its shares up nearly 8 percent.
The French government has agreed to subsidize a cervical cancer vaccine made by Merck for teenage girls and young women, according to Merck's marketing partner, French drugmaker Sanofi-Aventis.
GlaxoSmithKline announced the results of the biggest-ever study of a cancer vaccine Wednesday, in the hopes of bolstering the competitive strength of its Cervarix against Merck's Gardasil.
CEOs reveal the business strategies that put companies like Akamai, Netflix, and Priceline at the top of Business 2.0's ranking of the 100 fastest-growing technology companies.
GlaxoSmithKline PLC revealed Thursday that the U.S. Food and Drug Administration has declined to grant a priority review to its experimental cancer vaccine Cervarix
The drugmakers Merck, Schering-Plough and Wyeth all reported strong first-quarter earnings - with Schering and Wyeth trouncing forecasts - but investor reaction was mixed.
GlaxoSmithKline said it submitted an application for its cervical cancer vaccine Cervarix to the Food and Drug Administration, bringing it one step closer to challenging Merck's now-dominant Gardasil.
GlaxoSmithKline is getting closer to launching its challenge against Merck's monopoly on cervical cancer vaccines.
The Food and Drug Administration approved GlaxoSmithKline's breast cancer drug Tykerb, the drug company said Tuesday.
The Food and Drug Administration is expected to approve a breast cancer treatment from GlaxoSmithKline on Tuesday, analysts say.
The FDA's decision to grant over-the-counter status to GlaxoSmithKline's weight loss drug Alli could have big implications on national health, but the drug is not a miracle cure, experts said.
The British drugmaker GlaxoSmithKline fired a shot over Merck's bow on Thursday, by launching a study comparing its own experimental vaccine for cervical cancer to Merck's Gardasil.
Strange as it may seem, much of our failure in fighting cancer--and more important, much of the potential for finally winning this fight--has to do with a definition. Some 2,400 years ago the Greek physician Hippocrates described cancer as a disease that spread out and grabbed on to another part of the body like "the arms of a crab," as he elegantly put it. Similarly, medical textbooks today say cancer begins when the cells of an expanding tumor push through the thin protein "basement" membrane that separates them from another tissue. It's a fancy way of saying that to be cancer, a malignant cell has to invade another part of the body.
Big Pharma stocks trounced Big Biotech this year, as Merck and other drugmakers recovered from their woes, and Genentech slid after a couple of very good years.
On the site of a former amusement park in a small Pennsylvania town, technicians sheathed in plastic suits labor over stainless steel fermentation tanks that look like brewery vats.
Hey Big Pharma, listen up: this is NOT the time to be dropping the ball on a blockbuster.
Merck & Co. reported reduced earnings, but still managed to edge past Wall Street expectations, even though Vioxx-related lawsuits against the company continue to mount.
To quote Frank Sinatra, Big Pharma stocks are having "a very good year."
Big Pharma is feeling the squeeze as name-brand drugs go off patent, which is why analysts are expecting a flat or modest second quarter for most of the biggest U.S. drug makers.
Merck's stock price is starting to climb out of its hole this year, but the drug giant still faces a long uphill climb fraught with obstacles if it ever plans to get to its pre-Vioxx scandal levels.
The U.S. Food and Drug Administration on Thursday approved the first vaccine for cervical cancer -- Gardasil, manufactured by Merck and Co.
Federal regulators approved Gardasil, the first vaccine meant to prevent cervical cancer, the drugmaker Merck said Thursday.
Vital protection against cervical cancer could soon be made available, not just from Merck but also from GlaxoSmithKline, providing life-saving potential for women while feeding a competitive atmosphere for the drug giants.
Merck has already angered Christian conservatives by pushing to make its yet-to-be approved cervical cancer vaccine, Gardasil, mandatory for girls as young as nine. But that could be the least of the company's worries regarding the projected $4 billion-a-year vaccine.
The FDA has approved Zostavax, a new vaccine from Merck that prevents shingles, for patients 60 or older.
An FDA advisory committee recommended for approval Merck's experimental cervical cancer vaccine Gardasil, said Merck and the agency.
Merck needs a hit, and it just might be on the verge of getting one, thanks to some delicate footwork with the religious right.
Merck reported strong first-quarter profit Thursday, beating consensus projections on a slight increase in sales, and prompting the drugmaker to ramp up its earnings projection for the full year despite the imminent patent loss of its top-selling product, Zocor.
JUDGING BY THE HEADLINES, IT WOULD BE EASY TO THINK that Big Pharma is on the brink of collapse. In 2006 the industry is poised to lose more than $23 billion in sales to generic competitors, its wo...
Merck burned through nearly $300 million in 2005 defending itself against Vioxx-related lawsuits and shoring up its legal defenses against future cases, said CEO Richard Clark.
Merck's big problem in 2006 isn't just Vioxx. It's Zocor.
Judging by the headlines, it would be easy to think that Big Pharma is on the brink of collapse.
Merck, the second-biggest American drug maker, said on Friday that its experimental cervical cancer vaccine Gardasil can also prevent external genital lesions in women, including vaginal and vulvar lesions.
The mistrial in the third Vioxx case gave investors a scare on Monday, but analysts say that it changes little for Merck, which has an improving pipeline but still faces thousands of lawsuits and is unlikely to show real growth for years.
If the future of Big Pharma can be read in its pipelines, Eli Lilly & Co. and Sanofi-Aventis are among the few bright spots, analysts say -- but investors should also look at Pfizer, which is experimenting with a drug combo that could outsell all others.
Eliav Barr has popped the champagne. After a decade of development, his team at Merck has just finished presenting the clinical-trial results on the company's cervical cancer vaccine, Gardasil, to ...
Merck maintains its defense for Vioxx, the beleaguered painkiller that was pulled off the market in 2004 and has been blamed for heart attacks in a growing tally of lawsuits, a top company lawyer said Monday.
Researchers with Merck & Co. report they have been successful at blocking viruses that cause cervical cancer and lesions that become cancerous. About 20 million Americans are living with the virus.
HEART AND CARDIOVASCULAR
A cervical cancer vaccine that analysts are calling the biggest potential blockbuster in Merck & Co.'s pipeline passed the first phase in late-stage testing and will be filed with the Food and Drug Administration this year, the company said Thursday.
It's strange to think that I can still remember the smell after all this time. The year was 1978, not long after my 15th birthday, and I'd sneaked into my brother's bedroom. There, on a wall of she...
Journalists are a cynical lot. We are natural-born skeptics searching for the black clouds in every silver lining. Our mien is--well, how to put it?--mean.
Quick, what was the best-performing stock on the FORTUNE 500 last year? EMC? No way! Philip Morris? You're closer. Okay, here's a hint: Testing. Testing. One. Two. Three. In fact, the winner was th...
The pap smear test--a woman's primary means of detecting cervical cancer--celebrated its 50th birthday recently, and the years show. The false negative rate for the aging procedure is an unacceptab...
Few medical topics get as much scary press as genetic testing. The typical story: A person learns from a DNA test that he's inherited a faulty gene predisposing him to, say, a fatal brain disease y...
Everyone has a dream they'd like the stock market to fulfill--a vacation home, a child's education, a peaceful retirement. Yet identifying the companies that can provide such long-term riches is a ...
Remarkably, the Pap smear -- the most widely used cancer-screening test for women -- has not changed since 1950, when doctors started using it routinely to check for cervical cancer. Lab technician...
THEY MAKE your lip curl when you see them in the elevators at the office: those gaunt, humorless guys with gym bags who run a few dozen miles during their lunch hour before breezing through 400-pou...
| Most Viewed | Most Emailed | Top Searches |
© 2009 Cable News Network. Turner Broadcasting System, Inc. All Rights Reserved.
